Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-10

FDA Approved: EZETIMIBE — Supplemental Application (Marlex Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ezetimibe submitted by Marlex Pharmaceuticals, Inc., granting an update to the approved generic product under th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)